000 03861nam a22003855i 4500
001 100021
003 DE-He213
005 20230110040201.0
007 cr nn 008mamaa
008 180524s2018 xxu| s |||| 0|eng d
020 _a9781493977840
_9
024 7 _a10.1007/978-1-4939-7784-0
_2doi
040 _aES-MaUEC
_bspa
050 4 _aRC902 2018 EB
245 1 0 _aPolycystic Kidney Disease:
_bTranslating Mechanisms into Therapy
_cedited by Benjamin D. Cowley, Jr., John J. Bissler.
264 1 _aNew York
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XIII, 273 páginas 62 ilustraciones, 42 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
505 0 _aPART 1. POLYCYSTIC KIDNEY DISEASE GENES & PROTEINS -- 1. Classical Polycystic Kidney Disease (PKD): Gene Structures and Mutations and Protein Structures and Functions -- 2. Bardet-Biedl Syndrome -- 3. Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel Lindau, and Birt Hogg Dubé -- PART 2. POLYCYCSTIC KIDNEY DISEASE: MECHANISMS OF DISEASE -- 4. Aberrant Cellular Pathways in PKD -- 5. Cilia and Polycystic Kidney Disease -- 6. The Role of Inflammation and Fibrosis in Cystic Kidney Disease -- PART 3. CLINICAL FEATURES -- 7. Imaging-based Diagnosis of Autosomal Dominant Polycystic Kidney Disease -- 8. Renal Structural Involvement in Autosomal Dominant Polycystic Kidney Disease: Cyst Growth and Total Kidney Volume: Lessons from the Consortium for Radiologic Imaging of Polycystic Kidney Disease (CRISP) -- 9. Renal Complications: Pain, Infection and Nephrolithiasis -- 10. ADPKD Extrarenal Manifestations: Polycystic Liver Disease -- 11. Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease -- PART 4. CLINICAL TRIALS AND EMERGING THERAPIES -- 12. Role of Renin- Angiotensin- Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease -- 13. Vasopressin Receptor Antagonism -- 14. End-stage Renal Disease in Patients with Autosomal Dominant Polycystic Kidney Disease -- 15. Polycystic Kidney Disease: Translating Mechanisms into Therapy Management of ADPKD Today.
520 3 _aThis comprehensive guide to polycystic kidney disease captures the growing knowledge of this common, potentially-fatal and hereditary disease. The first two sections of the book provide an overview of PKD gene structures, mutations and pathophysiologic mechanisms. This is followed by chapters focused on PKD's clinical features, including renal and extrarenal manifestations, and appropriate management of patients. The final section covers current clinical trials and emerging therapies in PKD. Authored by experts in the field, this book provides the clinician and researcher with critical information on basic and translational science and clinical approaches in one concise resource.
650 7 _aRiñones
_xEnfermedades
_9168885
_2embne
650 7 _aNefrología
_2embne
_9143254
700 1 _aCowley, Jr., Benjamin D
_eeditor literario
700 1 _aBissler, John J
_eeditor literario
_0http://id.loc.gov/authorities/names/n2018188132
_0http://viaf.org/viaf/12154074360611740705
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9781493977826
776 0 8 _iEdición impresa:
_z9781493977833
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-7784-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490 0 _aMedicine (Springer-11650)
988 _aSpringer_Medicine_2018
998 _b02/2019
_dz
_ef
_feng
_ggw
_h0
999 _c100021
_d100021
_x1